Related Experiment Video
Updated: Nov 21, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Mortality trends in an ambulatory multidisciplinary heart failure unit from 2001 to 2018
Giosafat Spitaleri1, Josep Lupón1,2,3, Mar Domingo1
1Heart Failure Clinic and Cardiology Service, University Hospital Germans Trias I Pujol, Badalona, Spain.
Insights
Mortality significantly decreased in heart failure (HF) outpatients with reduced ejection fraction (LVEF < 50%) between 2001 and 2018. However, no significant mortality trend was observed in patients with preserved ejection fraction (LVEF ≥ 50%).
Area of Science:
- Cardiology
- Clinical Research
- Public Health
Background:
- Heart failure (HF) affects millions globally, with varying outcomes based on left ventricular ejection fraction (LVEF).
- Understanding long-term mortality trends in real-world HF cohorts is crucial for clinical practice and public health initiatives.
Purpose of the Study:
- To evaluate mortality trends over 18 years (2001-2018) in ambulatory heart failure patients.
- To compare mortality trends between patients with depressed (LVEF < 50%) and preserved (LVEF ≥ 50%) left ventricular ejection fraction.
Main Methods:
- A real-life cohort of 2368 HF outpatients was analyzed.
- Patients were stratified into five quintiles based on admission period (2001-2018).
- All-cause and cardiovascular mortality rates at 1 and 3 years were assessed using linear regression, adjusting for clinical factors.
Main Results:
- Patients with LVEF < 50% showed a significant progressive decrease in 1-year and 3-year all-cause and cardiovascular mortality.
- For LVEF < 50%, 1-year mortality dropped from 12.1% to 6.5% and 3-year mortality from 30.5% to 17.0% across quintiles.
- No significant mortality trend was observed in patients with LVEF ≥ 50%.
Conclusions:
- Mortality has progressively declined in ambulatory heart failure patients with depressed LVEF over the past two decades.
- This positive trend was not observed in heart failure patients with preserved LVEF.
- Further research is needed to understand and address the static mortality rates in the preserved LVEF subgroup.
Abstract:
To assess mortality trends at 1 and 3 years from 2001 to 2018 in a real-life cohort of HF outpatients from different etiologies with depressed and preserved LVEF. A total of 2368 consecutive patients with HF (mean age 66.4 ± 12.9 years, 71% men, 15.4% with preserved LVEF) admitted to a HF clinic from August 2001 to September 2018 were included in the study. Patients were divided into five quintiles (Q) according to the period of admission. Trends for all-cause and cardiovascular mortality from Q1 to Q5 were assessed by linear regression. Patients with LVEF < 50% had a progressive decrease in the rates of all-cause and cardiovascular death at 1 year (12.1% in Q1 to 6.5% in Q5, p = 0.003; and 8.4% in Q1 to 3.8% in Q5, p = 0.007, respectively) and 3 years (30.5% in Q1 to 17.0% in Q5, p = 0.003; and 23.9% in Q1 to 9.8% in Q5, p = 0.003, respectively). These trends remained significant after adjusting for clinical characteristics and risk. No significant trend in mortality was observed in patients with LVEF ≥ 50%. In a cohort of real-life ambulatory patients with HF, mortality progressively declined in patients with LVEF < 50%, but the same trend was not observed in patients with preserved LVEF.
Related Concept Videos
Heart Failure VII: Nursing Interventions
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure IV: Classification and Diagnostic Evaluation

